contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


invitation-to-presentation-of-meds-q3-2025-interim-report-on-november-7-2025

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Meds Apotek är ett fullskaligt e-handelsapotek verksamt på den svenska öppenvårdsmarknaden. Bolaget erbjuder sina kunder ett omfattande produktsortiment bestående av receptbelagda läkemedel, receptfria läkemedel och ett brett urval av handelsvaror såsom skönhetsprodukter, kosttillskott, barnprodukter, träningsprodukter, mat och dryck och hem & hushållsprodukter. Meds Apotek grundades år 2017 och har sitt huvudkontor i Stockholm.

Meds Apotek

MEDS will publish its interim report for the third quarter of 2025 on November 7, 2025, at 07:30 CET. A webcast presentation will be held at: https://www.finwire.tv/webcast/meds-apotek/meds-...

<div class="mfn-body">MEDS will publish its interim report for the third quarter of 2025 on November 7, 2025, at 07:30 CET. A webcast presentation will be held at: <a rel="noopener" href="https://www.finwire.tv/webcast/meds-apotek/meds-2025/">https://www.finwire.tv/webcast/meds-apotek/meds-2025/</a> for analysts, media, and investors at 10:00 CET the same day. The report will be presented by Björn Thorngren, CEO and co-founder, and Nick Mendola, CFO. The presentation will be conducted in English and broadcast live online. To register please email <a rel="noopener" href="mailto:ir@meds.se">ir@meds.se</a> at latest 09.00 CET on November 7, 2025.&nbsp; A recorded version of the presentation will also be available at: <a rel="noopener" href="https://www.finwire.tv/webcast/meds-apotek/meds-2025/">https://www.finwire.tv/webcast/meds-apotek/meds-2025/</a> &nbsp; Phone number for analysts: +46850163827, then enter the meeting ID: 81972913787 followed by # &nbsp; Schedule on the 7th of November:<ul><li>07:30 CET – Publication of the Q3 report</li><li>10:00 CET – Webcast and conference call with CEO Björn Thorngren and CFO Nick Mendola</li></ul>&nbsp; For further information, please contact: Frida Benno Hjerpe MEDS Press &amp; Investor Relations E-mail: <a rel="noopener" href="mailto:press@meds.se">press@meds.se</a> Web: <a rel="noopener" href="https://corporate.meds.se/">https://corporate.meds.se/</a><hr>About MEDS MEDS.se is a full-scale online pharmacy licensed by the Swedish Medical Products Agency. We provide both prescription and over-the-counter medicines for you, your family, and your pets. In addition, MEDS offers a wide range of products in health, beauty, and wellness.Certified advisor is FNCA.</div><div class="mfn-footer mfn-attachment mfn-attachment-general">Attachments<hr><a rel="noopener" href="https://storage.mfn.se/267b0e23-f821-4d9b-9b90-21bf62d1f943/invitation-to-presentation-of-meds-q3-2025-interim-report-on-november-7-2025.pdf" class="mfn-generated mfn-primary">Invitation to presentation of MEDS Q3 2025 Interim Report on November 7, 2025</a></div>